Plasmapheresis Device – Designed to improve the process of blood plasma collection

Plasmapheresis is a medical procedure designed to remove some plasma from the blood. It is done to treat various autoimmune disorders such as sickle cell anemia, chronic inflammatory demyelinating polyneuropathy, myasthenia gravis, lambert-eaton myasthenic syndrome, and guillain-barre syndrome, increasing the demand for plasmapheresis devices worldwide.

Therapeutic plasma exchange (TPE), or plasmapheresis, removes and replaces a patient’s blood plasma to treat certain diseases. Plasmapheresis can be accomplished through centrifuge-based platforms such as Fenwal Aurora, Cobe Spectra, and Fresenius COM.

Request Sample Copy of Plasmapheresis Device Report @
https://www.coherentmarketinsights.com/insight/request-sample/2259

Competitive Landscape:

Major players operating in the global plasmapheresis device market are Fresenius SE & Co. KgaA, Infomed SA, Haemonetics Corporation, Kaneka Corporation, Kawasumi Laboratories Inc., B. Braun Melsungen AG, Baxter International Inc., Terumo Corporation, Asahi Kasei Corporation, and Shanghai Dahua Medical Apparatus Co., Ltd.

Key Market Drivers:

Increasing prevalence of autoimmune disorders across the globe is expected to propel growth of the plasmapheresis device market during the forecast period. For instance, according to the National Stem Cell Foundation (NSCF), around 4% of the world’s population is affected by one of more than 80 different autoimmune diseases.

Moreover, the emergence of COVID-19 worldwide is expected to augment the growth of the plasmapheresis device market. For instance, in September 2020, Roche announced the launch of its Elecsys, a new quantitative antibody test to measure SARS-CoV-2 antibodies to support the evaluation of vaccines.

COVID-19 Impact Analysis:

Reducing the burden of cytokines and abnormal coagulation agents by plasmapheresis can be very helpful in the management of COVID-19. Therapeutic plasma exchange (TPE) is being discussed as a therapeutic alternative in COVID-19 patients. Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients. Moreover, in April 2020, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization for a blood purification system to treat patients 18 years of age or older with confirmed COVID-19 admitted to the ICU with confirmed or imminent respiratory failure. This in turn is expected to augment the growth of the plasmapheresis device market.

Request PDF Report Brochure @
https://www.coherentmarketinsights.com/insight/request-pdf/2259

Key Takeaways:

The plasmapheresis device market is expected to exhibit a CAGR of XX % during the forecast period owing to increase in approvals of plasmapheresis devices by government authorities. For instance, in July 2019, Baxter received the Food and Drug Administration (FDA) 510(k) clearance for the PrisMax system and integrated TherMax blood warmer, the company’s next-generation platform for continuous renal replacement therapy (CRRT) and therapeutic plasma exchange (TPE).

Among regions, North America is expected to witness robust growth in the plasmapheresis device market due to the increasing prevalence of autoimmune disorders in this region. Autoimmune diseases are a family of more than 80 chronic. For instance, according to the National Institutes of Health, around 23.5 million Americans (7% of the population) suffer from an autoimmune disease, and the prevalence is rising.

Buy This Complete A Business Report With Flat US $2000 Off @
https://www.coherentmarketinsights.com/promo/buynow/2259

Reasons to Purchase this Report

• Current and future of global Plasmapheresis Device market outlook in the developed and emerging markets

• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.

• Regions/countries that are expected to witness the fastest growth rates during the forecast period

• The latest developments, market shares, and strategies that are employed by the major market players

Table Of Content

Chapter No. 1 Introduction

1.1. Report Description

1.1.1. Purpose of the Report

1.1.2. USP & Key Offerings

1.2. Key Benefits for Stakehulders

1.3. Target Audience

1.4. Report Scope

Chapter No. 2 Executive Summary

2.1. Key Findings

2.1.1. Top Investment Pockets

2.1.1.1. Market Attractiveness Analysis, By Type

2.1.1.2. Market Attractiveness Analysis, By End Use

2.1.1.3. Market Attractiveness Analysis, By Region

2.2. Market Snapshot

2.3. Global Plasmapheresis Device Market, 2016 – 2021 (USD Million)

2.4. Insights from Primary Respondents

Chapter No. 3 COVID 19 Impact Analysis

3.1. Impact Assessment of COVID-19 Pandemic, By Region

3.1.1. North America

3.1.2. Europe

3.1.3. Asia Pacific

3.1.4. Latin America

3.1.5. The Middle-East and Africa

Customization of the Report

In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.

Also, Research Report Examines:

• Competitive companies and manufacturers in global market

• By Product Type, Applications & Growth Factors

• Industry Status and Outlook for Major Applications / End Users / Usage Area

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.